GeNeuro S.A. | Mutual Funds

Mutual Funds that own GeNeuro S.A.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
LBPAM Actions Santé
75,731
0.52%
19,361
0.33%
06/29/2018
Etoile Santé Europe
54,310
0.37%
0
0.18%
01/31/2018
JPMorgan Funds - Global Healthcare Fund
53,780
0.37%
-8,239
0.01%
05/31/2018
Falcon Fund SICAV - Small & Mid Cap Equity Fund
39,034
0.27%
0
0.65%
12/31/2017
Aviva Investors - European Equity Fund
30,294
0.21%
0
0.1%
06/30/2018
Aviva Investors Investment Funds ICVC - European Equity Fund
27,553
0.19%
0
0.07%
10/15/2017
Soprane Gestion Optimum
9,000
0.06%
0
0.78%
06/30/2017
CD Euro Capital
6,000
0.04%
0
0.12%
06/29/2018
0
0%
-112,509
0%
12/31/2017

About GeNeuro

View Profile
Address
3, Chemin du Pré-Fleuri
Plan-les-Ouates Geneve (Geneva) 1228
Switzerland
Employees -
Website http://www.geneuro.ch/fr/accueil
Updated 07/08/2019
GeNeuro SA engages in the research and development of pharmaceutical products. It offers GNbAC1, a therapeutic antibody that targets MSRV-Env. It also offers a drug for multiple sclerosis.